Genetic testing for IRDs varies widely across the RI membership
News
World Retina Day 2018
Luxturna, the first treatment option for hereditary retinal dystrophy with mutations of the RPE65 gene, recommended for approval by the European Medicines Agency
World Eye and Vision Congress 2018
18th International Conference on Glaucoma & Retinal Diseases
XXII Biennial Meeting of the International Society for Eye Research
WORLD EYE AND VISION CONGRESS 2018
Patient information day for families affected by RDH12-related eye conditions
RDH12 gene patient information day
RP Fighting Blindness Conference
Industry News: MeiraGTx Ltd Announces Fast Track designation of gene therapy candidate for X-linked retinitis pigmentosa (XLRP)
-
close